A Randomized Open Label Study of KLH-2109 in Patients With Endometriosis(1)

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain

NCT05445167 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Efficacy and Safety of OBE2109 in Subjects With Endometriosis

NCT02778399 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of BG2109 in Chinese Subjects With Endometriosis

NCT05894135 ·Status: UNKNOWN ·Phase: PHASE3

Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain

NCT04372121 ·Status: TERMINATED ·Phase: PHASE3

A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

NCT05560646 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of MT-2990 in Women With Endometriosis

NCT03840993 ·Status: COMPLETED ·Phase: PHASE2

BGS649 Monotherapy in Moderate to Severe Endometriosis Patients

NCT01190475 ·Status: COMPLETED ·Phase: PHASE2

Levonorgestrel-releasing Intrauterine System in Patients With Endometriosis

NCT02158845 ·Status: COMPLETED ·Phase: PHASE4

Endometriosis Trial: Study of NBI-56418 in Endometriosis

NCT00109512 ·Status: COMPLETED ·Phase: PHASE2

A Survey on Efficacy and Safety in Patients With Endometriosis

NCT02921763 ·Status: COMPLETED

The Impact of a Novel GnRH Antagonist With Add-back Therapy for Treatment of Uterine Fibroids and Endometriosis on Hemostasis Parameters

NCT07173127 ·Status: RECRUITING ·Phase: NA

Efficacy and Safety of TAK-385 in the Treatment of Endometriosis

NCT01458301 ·Status: COMPLETED ·Phase: PHASE2

A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients With Moderate to Severe Endometriosis-Associated Pain

NCT06963177 ·Status: RECRUITING ·Phase: PHASE2

Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain (EDELWEISS 6)

NCT04335591 ·Status: COMPLETED ·Phase: PHASE3

Subdermal Implant-bioabsorbable Gestrinone Pellet for Endometriosis Pelvic Pain Treatment

NCT05570786 ·Status: COMPLETED ·Phase: PHASE2

A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis

NCT01116440 ·Status: TERMINATED ·Phase: PHASE2

Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women

NCT00318500 ·Status: COMPLETED ·Phase: PHASE2

Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain

NCT02143713 ·Status: COMPLETED ·Phase: PHASE3

The Pharmacokinetic(PK)/Pharmacodynamics(PD) Study of SHR7280 Tablets in Premenopausal Subjects With Endometriosis.

NCT04417972 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy

NCT04756037 ·Status: COMPLETED ·Phase: PHASE3

A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis

NCT01452685 ·Status: COMPLETED ·Phase: PHASE2

Letrozole in the Treatment of Severe and Recurrent Endometriosis

NCT00240942 ·Status: COMPLETED ·Phase: PHASE2

Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study

NCT02542410 ·Status: COMPLETED ·Phase: PHASE2

Adenomyosis and Ulipristal Acetate

NCT02587000 ·Status: COMPLETED ·Phase: PHASE2

Medroxyprogesterone Acetate vs LNG-IUS in Early-stage Endometrioid Carcinoma and Atypical Hyperplasia Patients

NCT05565573 ·Status: RECRUITING ·Phase: PHASE2/PHASE3